ghk cu clinical trial GHK-Cu Repairing Serum | Barrier Repair Serum Injectable Peptides for Anti-Aging? A

Aljarb, A

Side Effects and Safety# Epitalon Safety Profile# Preclinical record: No significant adverse effects across decades of animal studies Injection site effects: Mild redness and transient discomfort at injection sites Cancer concern: Telomerase activation theoretically risks promoting pre-cancerous cells, though Epitalon studies showed reduced rather than increased tumor incidence Limitation: Safety data predominantly from a single research group without large-scale, independent safety assessments NAD+ Safety Profile# Human trial data: NMN (250-1200 mg/day) and NR (300-2000 mg/day) have shown favorable safety in multiple human studies lasting weeks to months Common effects: Mild GI symptoms (nausea, bloating) at higher doses

While beta-3 receptor density varies between fat depots (higher in visceral, moderate in abdominal subcutaneous, lower in gluteal-femoral), the peptide works systemically

Less daily physical limitation from injuries youve been managing for months or years

The Regents of the University of Michigan.